Daniel P Morin
Overview
Explore the profile of Daniel P Morin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
112
Citations
818
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Omland T, Rosjo H, Wisloff T, Bernard M, Hiltbold A, Khatib S, et al.
Clin Biochem
. 2024 Dec;
135():110868.
PMID: 39706544
Background: Secretoneurin, a member of the granin protein family, is associated with the risk of mortality in patients with acute and chronic heart failure. Secretoneurin may play an important role...
3.
Reed S, Harrington J, Morin D, Saba S, Montgomery J, Harrison R, et al.
JACC Adv
. 2024 Nov;
3(12):101370.
PMID: 39568653
Background: Quantifying patients' preferences for health outcomes associated with atrial fibrillation (AF) and its treatments offers a replicable approach to considering the patient perspective in regulatory decision-making. Objective: The authors...
4.
Shah N, Mulder H, Lydon E, Chiswell K, Hu X, Lampron Z, et al.
J Am Heart Assoc
. 2024 Nov;
13(21):e035610.
PMID: 39494552
Background: Lipoprotein (a) is an independent risk factor for atherosclerotic cardiovascular disease. However, lipoprotein (a) testing remains variable and it is unclear what factors influence testing and if testing changes...
5.
Bober R, Milani R, Abelhad N, Velasco-Gonzalez C, Stewart M, Morin D
J Nucl Cardiol
. 2024 Oct;
41:102059.
PMID: 39426501
Background: On legacy 2D positron emission tomography (PET) systems utilizing a 50 mL/min Rb-82 profile, test-retest precision of quantitative perfusion is ∼10%. It is unclear whether Rb-82 infusion rate significantly...
6.
Shah N, Mulder H, Lydon E, Chiswell K, Hu X, Lampron Z, et al.
Am Heart J
. 2024 Oct;
279:50-58.
PMID: 39423990
Background: Although guidelines recommend low-density lipoprotein cholesterol (LDL-C) to be < 70 mg/dL in patients with atherosclerotic cardiovascular disease (ASCVD), the rate of achieving this goal remains suboptimal. We sought...
7.
Cha Y, Bhakta D, Barbhaiya C, Chung E, Fisher J, Fix A, et al.
Heart Rhythm
. 2024 May;
21(6):975-977.
PMID: 38816149
No abstract available.
8.
Aymond J, Sanchez A, Castine M, Bernard M, Khatib S, Hiltbold A, et al.
JAMA Cardiol
. 2024 May;
9(7):641-648.
PMID: 38776097
Importance: Atrial fibrillation and obesity are common, and both are increasing in prevalence. Obesity is associated with failure of cardioversion of atrial fibrillation using a standard single set of defibrillator...
9.
Quesada A, Quesada-Ocete J, Quesada-Ocete B, Gonzalez-Ritonnale A, Marcaida-Benito G, Moral-Ronda V, et al.
Curr Probl Cardiol
. 2024 May;
49(7):102608.
PMID: 38697331
Background: No studies have been conducted to analyze the impact of serum uric acid (UA) levels on the outcome of atrial fibrillation (AF) patients. We aimed to evaluate the effect...
10.